Mitiglinide
Mitiglinide (INN, trade name Glufast) is a drug for the treatment of type 2 diabetes. Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Mitiglinide
Mitiglinide (INN, trade name Glufast) is a drug for the treatment of type 2 diabetes. Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.
has abstract
Mitiglinide (INN, trade name G ...... s not yet gained FDA approval.
@en
ミチグリニド は、グリニド系経口血糖降下薬の一つ。2型糖尿病 ...... から、「グルファスト」として同一ブランド名で併売されている。
@ja
alternative name
Glufast
@en
CAS number
145375-43-5
ChEMBL
DrugBank
FDA UNII code
D86I0XLB13
KEGG
PubChem
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
981,898,971
Link from a Wikipage to another Wikipage
ATC prefix
A10
@en
ATC suffix
BX08
@en
CAS number
ChEMBL
ChemSpiderID
DrugBank
DB01252
@en
IUPAC name
--α-Benzylhexahydro-γ-oxo-2-isoindolinebutyric acid
@en
KEGG
D01854
@en
PubChem
routes of administration
By mouth
@en
SMILES
O=C[C@@H]CCN3C[C@H]2CCCC[C@H]2C3
@en
StdInChIKey
WPGGHFDDFPHPOB-BBWFWOEESA-N
@en
tradename
Glufast
@en
UNII
D86I0XLB13
@en
Verifiedfields
changed
@en
verifiedrevid
462,252,797
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
Mitiglinide (INN, trade name G ...... s not yet gained FDA approval.
@en
ミチグリニド は、グリニド系経口血糖降下薬の一つ。2型糖尿病 ...... から、「グルファスト」として同一ブランド名で併売されている。
@ja
label
Mitiglinide
@en
ミチグリニド
@ja